Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2013 · 10-Q
Revenue$1.41M$1.41M−27.7% vs Q2 2012 Net Income-$3.21M-$3.21MN/M vs Q2 2012 EPS Diluted-$0.05-$0.05N/M vs Q2 2012 Gross Profit$800,000−12.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$7,720,000N/M Free Cash Flowderived-$8,071,000N/M Margins · derivedGross margin56.8%+9.8 pt vs Q2 2012
Operating margin-451.9%−94.4 pt vs Q2 2012
Net margin-228.1%+176.8 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 9, 2013 · 40 d after period end